NCT03092076View on ClinicalTrials.gov

The Impact of Genotype on Pharmacokinetics and Antiplatelet Effects of Ticagrelor in Healthy Chinese

PHASE1CompletedINTERVENTIONAL
Enrollment

51

Participants

Timeline

Start Date

May 20, 2015

Primary Completion Date

October 24, 2015

Study Completion Date

June 16, 2016

Conditions
Healthy
Interventions
DRUG

Ticagrelor

180 mg loading dose

All Listed Sponsors
lead

Guangdong Provincial People's Hospital

OTHER

NCT03092076 - The Impact of Genotype on Pharmacokinetics and Antiplatelet Effects of Ticagrelor in Healthy Chinese | Biotech Hunter | Biotech Hunter